Neurotransmitter-Loaded DNA Nanocages as Potential Therapeutics for α-Synuclein-Based Neuropathies in Cells and In Vivo
{{output}}
Parkinson's disease is one of the neuropathies characterized by accumulation of the α-synuclein protein, leading to motor dysfunction. Levodopa is the gold standard treatment; however, in long-term usage, it leads to levodopa-induced dyskinesia (LID). New th... ...
